EPISODE · Dec 19, 2025 · 52 MIN
“We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation
from Citeline Podcasts · host Norstella
Matthew Wood, director and chief scientific officer at Oxford-Harrington Rare Disease Center, discusses the state of rare disease R&D, the evolving landscape of genomics and genetic therapies, and the challenges around the biopharma industry’s narrow focus on only 5-10% of rare diseases.
Embed this episode
NOW PLAYING
“We Are On The Cusp Of A Real Revolution”: OHC Rare Disease Center Boosts Innovation
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.